Post #199 by rnam on the Falling Knives board

Investment Strategies / Falling Knives

Unthreaded | Threaded | Whole Thread (34)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 5

Pfizer is now trading below its price 10 years ago. It is down 38% for the year.

I am not sure the chart I see in Seeking Alpha is adjusted for spin-offs like Zoetis and Viatris. Zoetis has performed well since spin-off.

Pfizer, like Citi and AT&T seems to be a permanent presence on the Falling Knives board. All the COVID windfall pissed away on costly acquisitions, to fill pipelines their own R&D can’t deliver.

Anyone see light at the end of the tunnel? For the perennially optimistic, call options are fairly cheap.

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (34)

Prev | Next

Announcements

Falling Knives FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.